Congreso de Citopatología *

ASC y SEC

UNIVERSIDAD de NAVARRA

PAMPLONA ESPAÑA

9 -10 de septiembre de 2021

*Solicitada la acreditación a la Comisión de Formación Continuada de las Profesiones Sanitarias de la Comunidad de Madrid

Directores del Congreso

Organizadores

Maria D. Lozano

MD, PhD, MIAC.

Syed Z. Ali

MD, FRCPath, FIAC.

  • María D. Lozano
  • José Echeveste
  • Carlos de Andrea
  • Marta Abengózar
  • Laura Álvarez Gigli
  • Allan Argueta
  • Laura García Tobar
  • José J Paricio
  • Guillermo García
  • Tania Labiano

Ponentes

S. Ali

Syed Z. Ali

MD, FRCPath, FIAC.

Professor of Pathology and Radiology.
Director of Cytopathology.
The Johns Hopkins Hospital. Baltimore, USA

Dr. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital in New York with fellowships in Surgical Pathology at the Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital.

Known globally as an innovative educator, Dr. Ali has well over 350 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.

Dr. Ali has published extensively with over 300 articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” has been translated in 7 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and has served as member of the executive board and chair of the scientific program committee and the educational development committee of the American Society of Cytopathology (ASC). He is a past-President of the ASC, and presently serves as the Vice President of the International Academy of Cytology (IAC) and chair of the International Board of Cytopathology of the IAC. He is a fellow of both, the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, the “President’s Award” in 2012, “Excellence in Education Award” in 2015 and the IAC’s “Maurice Goldblatt Award” in 2019.

Dr Paul Illei

Peter B Illei

MD. Associate Professor of Pathology and Oncology

Division of Cytopathology
Johns Hopkins Medical Institutions

Dr. Peter Bela Illei is an associate professor of Pathology and Oncology at the Johns Hopkins University School of Medicine and a member of the Division of Cytopathology. His areas of clinical expertise include cytopathology, pulmonary pathology, transplant pathology, and lung cancer biomarkers.

Dr. Illei earned his medical degree from The University of Pécs School of Medicine in Hungary. He completed a pathology residency at New York University Medical Center followed by fellowships in oncologic surgical pathology and cytopathology at Memorial Sloan Kettering Cancer Center. Following his fellowship he was a visiting investigator in the Kettering Institute at Memorial Sloan Kettering Cancer Center. He then joined the Department of Pathology of NYU School of Medicine and subsequently Johns Hopkins University School of Medicine. He also served as the director of the Immunohistochemistry Laboratory at the Johns Hopkins Hospital. Currently, Dr. Illei leads the Thoracic Pathology consult service of the Department.

Dr. Illei’s research interests include development of novel immunohistochemical and molecular markers for the diagnosis of solid tissue tumors, pathology of lung cancer and mesothelioma, as well as lung transplantation.

Dr. Illei served on several institutional committees, and as expert or review panel member of national organizations (CAP, USCAP, ASC, ACCP). He is currently serving as editorial board member of the journals and reviewers of over a dozen pyblications. He was invited speaker and workshop faculty at both national and international pathology/cytopathology conferences, and has authored 136 peer reviewed publication and two book chapters.

Philippe Vielh

MD, PhD, FIAC.

Professor of Pathology
Medipath & American Hospital of Paris, France

Dr. Philippe Vielh directed the cytopathology unit at Institut Curie (Paris, France) for 13 years before moving to Gustave Roussy comprehensive cancer center (Villejuif, France) where he headed the cytopathology unit (2003-2015), the histocytopathology unit of the translational research laboratory (2007-2014), and the institutional biobank (2011-2014). He then worked (2015-2019) at the Laboratoire National de Santé (Dudelange, Luxembourg) where he was mainly in charge of cytopathology. He is now working at Medipath and the American Hospital of Paris (France).

Dr Vielh is interested in the study of omics of breast and thyroid tumors. He has authored more than 320 articles in peer-reviewed journals, 7 books and 30 book chapters.

Philippe Vielh is currently the Editor-in-Chief of the journal Cytopathology since January 2021, Associate Editor of the Journal of Molecular Pathology since July 2020 and has been the series’ Editor of the Karger book collection entilted « Monograph in Clinical Cytology » between 2016 and 2020.

He is on the editorial board and reviews for Archives of Pathology and Laboratory Medicine, Diagnostic Cytopathology, Cancer Cytopathology, Acta Cytologica, Journal of the American Society of Cytology, Journal of Pathology and Translational Medicine, Cytopathology, and Cytojournal.

He is member of the American Society of Cytopathology (ASC) and holds a number of national and international society memberships including the fellowship of the International Academy of Cytology (FIAC).

Philippe was honored to serve as President of the French Society of Cytology (SFCC) for 9 years (1996-2006), President of the 31st European Congress of Cytology in 2005 (Paris, France) and Secretary General of the European Federation of Cytology Societies (EFCS) for 7 years (2005-2012). He chaired the 18th International Congress of Cytology in Paris (May 2013), was President of the International Academy of Cytology (IAC) for 3 years (May 2013-June 2016) and then IAC Past-President until May 2019. He is now Chair of the European Society of Pathology (ESP) Cytopathology Working Group since 2018.

Philippe is Professor of Pathology affiliated at the Faculty of Medicine of the University of Porto (Portugal) since December 2017.

He is recipient of the 2007 Papanicolaou Society of Pathology’s L.C. Tao “Educator of the Year” Award, the 2016 International Academy of Cytology’s Maurice Goldblatt Award and the 2019 American Society of Cytopathology’s International Achievement Award.

Fernando Schmitt

Fernando Schmitt

MD, PhD, FIAC

Professor of Pathology at Medical Faculty of Porto University
Head, Molecular Pathology Unit, IPATIMUP. Porto, Portugal

Professor Fernando Schmitt is Professor of Pathology at the University of Porto, Director of RISE (Clinical and Translational Research Network of the Medical Faculty) and Head of Molecular Pathology Unit at IPATIMUP, Past-President of the International Society of Breast Pathology and General Secretary and President-elect of the International Academy of Cytology (IAC).

He has authored more than 500 papers in peer-review journals, 33 book chapters and he is editor of six books, one of molecular pathology, one of molecular cytology, one in serous effusions, other of cytopathology and other two of breast cytopathology.

Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was Professor of Pathology at the University of São Paulo (USP), Brazil and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material.

Fernando serves as Editor in Chief of Pathobiology and Associate Editor of six major scientific journals and sits on the editorial board of many others. He is standing member of WHO Classification of Tumours – International Academy of Cytology. He has also been chair, president or scientific director of several major European, Portuguese and Brazilian scientific societies of pathology and cytology. Fernando received the following prizes: Educator of the Year 2011 by the Papanicoloau Society of Cytology (USA), GOLDBLATT AWARD 2013 from the International Academy of Cytology, Dario Cruz 2018 from the Portuguese League Against Cancer for his career as researcher in breast cancer and 2021 International Achievement Award from the American Society of Cytopathology.

Belén Lloveras

MD, PhD, FIAC.

Past-President of the Spanish society of cytopathology
Director of Pathology & Cytopathology.
Hospital del Mar. Barcelona

Dr.Belen Lloveras is Chairman of the Pathology Department at Hospital del Mar in Barcelona. She is specialist in Cytopathology, Gyneopathology and Endocrine pathology. Her research is focused on HPV related disease and has been actively involved in introducing HPV-based screening for cervical cancer in Spain. She is the past-President of the Spanish Society of Cytology and Professor of Pathology at the Autonomous University of Barcelona.

Paul E. Wakely, Jr.

MD.

Professor of pathology. The Ohio State University Wexner Medical Center.
James Cancer Hospital And Solove Reaearch Institute. Columbus, Ohio. USA

Dr. Paul Wakely, Jr. is a tenured Professor in the Department of Pathology, College of Medicine at The Ohio State Wexner Medical Center, James Cancer Hospital and Solove Research Institute and an Adjunct Professor in the Department of Otolaryngology.

He subspecializes in head and neck, soft tissue/bone surgical pathology and cytopathology. A graduate of St. Louis University School of Medicine, he began his pathology training at the U. of Michigan, Ann Arbor, MI. after completing a residency in clinical pediatrics. Further training consisted of a fellowship in pediatric pathology in Cincinnati, OH, and laboratory medicine training at the Johns Hopkins Hospital, Baltimore, MD. After 11 years at the Medical College of Virginia, and brief tenures in private practice, he has been at the OSU Wexner Medical Center since 1998.

He has over 220 peer-reviewed publications, has authored or co-authored 17 book chapters and monographs, and is the author, co-author, or co-editor of 6 texts in pathology. He previously served as Associate Editor for Journal of American Society of Cytopathology (JASC), and Cancer Cytopathology. He is currently a member of the editorial boards of the journals Seminars in Diagnostic Pathology, JASC, and Annals of Diagnostic Pathology. Dr. Wakely has lectured at multiple venues in the U.S., and abroad.

María D. Lozano

MD, PhD, MIAC.

President of the Spanish society of cytopathology
Director of Pathology & Cytopathology.
Clínica Universidad de Navarra. Pamplona
Associate professor of pathology.
Medical Faculty of University of Navarra. Pamplona

Dr. Lozano graduated and obtained PhD in Medicine and Surgery from the University of Navarra. She specialized in Pathology at the University Clinic of Navarra (CUN). Dr. Lozano completed a postdoctoral stay at the University of Nebraska Medical Center, in the Department of Pathology and Microbiology (March 1993-April 1995). Currently, Dr. Lozano is director of the Department of Pathology of the Clínica Universidad de Navarra, Pamplona, and Head of cytopathology and molecular pathology in cytology. Dr. Lozano is Associate Professor of Pathology at Medical School of the University of Navarra. She is the President of Spanish Society of Cytopathology.
Active member of SEAP (Sociedad Española de Anatomía Patológica), SEC (Sociedad Española de Citología), ESP (European Society of Pathology and Member of the Cytopathology Working group), ASC American Society of Cytopathology , IAC (International Academy of Cytology).
Member of the expert panel for biomarker guidelines of the Spanish Societies of Pathology and Medical Oncology (SEOM).
Member of Editorial boards of Several journals
As researcher, Dr. Lozano is part of multidisciplinary teams within the university itself, as well as national and international levels. She has special dedication to lung and pancreas cytopathology as well as great interest and extensive experience in new approaches of FNAB and the development and application of molecular techniques in cytological samples and small samples by obtaining material using minimally invasive methods. She is deeply involved in the study of tumor microenvironment in lung and pancreatic tumors. She dedicates also to surgical pathology of Lung and Mediastinum.
Dr. Lozano has written more than 190 articles in national and international scientific journals. She has presented more than 400 communications to meetings, more than 200 lectures given, as well as several courses on FNA and molecular biology applied to cytopathology.

Programa

DÍA UNO: JUEVES, 9 de septiembre de 2021

8:00
Inscripción. Documentación

8.30a
Apertura y presentación (Syed Ali, Maria D. Lozano)

8.45 – 10.15a
1. Citopatología del Tiroides – Bethesda 2010, 2017 y más allá – S. Ali
2. Nódulos tiroideos: Enfoque diagnóstico multimodal y hallazgos en el seguimiento – S. Ali

10.15 – 10.30a
Pausa – Café

10.30 – 11.30a
El Sistema Milan System para reporter Citopatología de Glándula slival  – P. Vielh

11.30 – 12.30p
Citopatología de lesiones de cabeza y cuello no salivares/ No tiroideas – P. Wakely

12.30 – 13.30p
Comida

1.30 – 2.30p
Citopatología de lesiones de tejido s blandos: Combinación de la morfología con las pruebas complementarias para un diagnóstico de precisión – P. Wakely

2.30 – 2.45p
Pausa – Café

2.45 – 4.30p
El Sistema Internacional para informar sobre la citopatología de líquidos corporales – F. Schmitt

4.30 – 5.15p
El Sistema Paris para informar sobre la Citopatología de orina – P. Vielh

5.15 – 5.30p
ICC 2022 – Baltimore (Un cortometraje)

DÍA DOS: VIERNES, 10 de septiembre de 2021

8.30 – 9.30a
El sistema Yokohama de la Academia Internacional de Citología para informar sobre la citopatología de la biopsia de mama por aspiración con aguja fina – F. Schmitt

9.30 – 10.30a
Retos diagnósticos en citopatología pulmonar –  MD Lozano

10.30 – 10.45a
Pausa – Café

10.45 – 11.45p
Manejo del cáncer de pulmón – Papel crítico de la citopatología – P. Illei

11.45 – 12.30p
Inmunotinciones en Citopatología: Lo bueno, lo malo y lo innecesario – P. Illei

12.30 – 1.30p
Comida

1.30 – 2.30p
Citopatologá Pancreática – “Caminando en la cuerda floja” – S. Ali

2.30 – 3.30p
El papel del VPH y las pruebas complementarias en la citología ginecológica – B. Lloveras

3.30 – 3.45p
Pausa – Café

3.45 – 4.30p
Citología cervical: Visión general y desafíos – S. Ali

4:30 – 5.30p        
Desafiando incógnitas desde dos lados del Atlántico Ali y Lozano

5.30p        
Cierre del curso – S.Ali y MD Lozano

Inscripción

Traducción simultánea

La inscripción da derecho a la asistencia a todas las sesiones de trabajo, cafés y almuerzos los días 9 y 10 de septiembre de 2021.

Patólogos

€ 250

Residentes

€ 200

Citotécnicos

€ 150

Localización

Alojamiento y Ocio